Simultaneous Prediction of Intestinal Absorption and Metabolism Using the Mini-Ussing Chamber System.


Journal

Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 27 06 2018
revised: 11 10 2018
accepted: 11 10 2018
pubmed: 6 11 2018
medline: 20 2 2020
entrez: 4 11 2018
Statut: ppublish

Résumé

The purpose of this study was to investigate the possibility of simultaneous prediction of the intestinal absorption and metabolism in a mini-Ussing chamber equipped with rat intestinal tissues, based on the transport index (TI). TI value was defined as the sum of drug amounts, by mass balance method, transported to the basal-side component and drug amounts accumulated in the tissue, which are normalized by area under the curve of the drug in the apical compartment. Midazolam and nifedipine with high permeability were used as typical P450 substrates to examine the possibility of simultaneous prediction of intestinal absorption and metabolism. The metabolite formation of both compounds was observed and ketoconazole strongly inhibited the metabolite formation of both compounds in rat intestinal tissues, leading to the improvement of the TI value to a statistically significant extent for both compounds. TI ratio of nifedipine between in the presence and absence of ketoconazole was larger than that of midazolam, which was consistent with the reported lower value of fraction absorbed multiplied by intestinal availability of nifedipine. Therefore, the mini-Ussing chamber, equipped with animal intestinal tissues, showed potential to predict the intestinal absorption and metabolism simultaneously.

Identifiants

pubmed: 30389567
pii: S0022-3549(18)30678-6
doi: 10.1016/j.xphs.2018.10.046
pii:
doi:

Substances chimiques

Pharmaceutical Preparations 0
Nifedipine I9ZF7L6G2L
Midazolam R60L0SM5BC
Ketoconazole R9400W927I

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

763-769

Informations de copyright

Copyright © 2019 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Auteurs

Satoshi Kondo (S)

Department of Drug Metabolism and Pharmacokinetics, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co. Ltd., 460-10 Kagasuno Kawauchi-cho, Tokushima 771-0192, Japan; Department of Drug Safety Research, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., 460-10 Kagasuno Kawauchi-cho, Tokushima 771-0192, Japan.

Masateru Miyake (M)

Bioavailability Research Project, Formulation Research Institute, Otsuka Pharmaceutical Co. Ltd., 224-18 Ebisuno Hiraishi Kawauchi-cho, Tokushima 771-0182, Japan; Quality Assurance Section, Quality Assurance Department, Headquarters for Product Safety and Quality Assurance, Otsuka Pharmaceutical Co. Ltd., Matsudani Itano-cho, Itano-gun, Tokushima 779-0195, Japan. Electronic address: Miyake.Masateru@otsuka.jp.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH